Nymbl Science
Denver, US · Founded 2018 · Delaware corporation · 9 known investors
Founders & leadership
EL
Edward LikovichExecutive
JC
James CookNamed on SEC filing
Board
TV
Thomas VirdenBoard director
CS
Chris SaxmanBoard director
RS
Rohit SethBoard director
MO
Meghan OliverBoard director
DE

Investors · 9
Allied Venture PartnersCalgary · $100K – $350K
Cobalt VenturesKansas City · $10M – $75M
FemHealth VenturesShort Hills
Forefront VentureSeattlevia Phil Nadel · inferred
Healthtech CapitalSilicon Valley
Rockies Venture ClubDenver · $100K – $500K
Social StartsSan Francisco
Third Act VenturesSan Diegovia Max Zamkow · inferred
Rockies Venture Adviser, LlcreportedDenver · $100K – $500Kvia Chris Saxman · board
Reported raises · per SEC filings
Form D private placements$15.8M disclosed across 4 rounds · 2019–2025
▶$984.1KraisedSep 2025 · 30 investors · Other Health CareRule 506(b)
▶$984.1KraisedSep 2025 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas VirdenDirector
- Ben WireDirector
- Edward LikovichExecutive Officer, Director
- Chris SaxmanDirector
- Rohit SethDirector
- Meghan OliverDirector
- David EichlerDirector
- Offering amount
- $2.4M
- Amount sold
- $984.1K
- Minimum investment
- $1
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.8MraisedDec 2022 · 23 investors · Other Health CareRule 506(b)
▶$8.8MraisedDec 2022 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David EichlerDirector
- Thomas VirdenDirector
- Edward LikovichExecutive Officer, Director, Promoter
- Chris SaxmanDirector
- Rohit SethDirector
- Philip LinvilleDirector
- Meghan OliverDirector
- Offering amount
- $13M
- Amount sold
- $8.8M
- Minimum investment
- $10K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3.7MraisedOct 2020 · 22 investors · Other Health CareRule 506(b)
▶$3.7MraisedOct 2020 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Caroline Owen-JonesPromoter
- Dr. Jean-Pierre FarcyPromoter
- Chris SaxmanDirector
- Thomas VirdenDirector, Promoter
- Edward LikovichExecutive Officer, Director, Promoter
- James CookDirector, Promoter
- Meghan OliverDirector
- Offering amount
- $4M
- Amount sold
- $3.7M
- Minimum investment
- $4K
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.3MraisedAug 2019 · 27 investors · Other TechnologyRule 506(b)
▶$2.3MraisedAug 2019 · 27 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Dr. Jean-Pierre FarcyPromoter
- Thomas VirdenExecutive Officer, Director, Promoter
- Edward LikovichExecutive Officer, Director
- James CookExecutive Officer, Director, Promoter
- Chris SaxmanDirector
- Carol Owens JonesPromoter
- Offering amount
- $2.7M
- Amount sold
- $2.3M
- Minimum investment
- $10K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Nymbl Science for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who are Nymbl Science's investors?
- Nymbl Science's investors include Allied Venture Partners, Cobalt Ventures, FemHealth Ventures, Forefront Venture, Healthtech Capital, Rockies Venture Club, Social Starts, Third Act Ventures and 1 more.
- How much funding has Nymbl Science raised?
- Nymbl Science has disclosed $15.8M raised across 4 rounds.
- Where is Nymbl Science headquartered?
- Nymbl Science is headquartered in Denver, US.



